PaySign, Inc.

PaySign, Inc. Q3 2026 Earnings Recap

PAYS Q3 2026 Published November 14, 2026

Get alerts when PAYS reports next quarter

Set up alerts — free

PaySign shares fell 18.9% after earnings, with the planned loss of payment processing at 113 plasma centers likely weighing on investors despite rapid patient-affordability growth. The transition is expected to be completed in Q4, and management said it expects new centers to offset the loss over the next couple of quarters.

Earnings Per Share Beat
$0.11 vs $0.09 est.
+22.2% surprise
Revenue Beat
30800160 vs 29019200 est.
+6.1% surprise

Market Reaction

Post-Earnings -18.94%

See PAYS alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Revenue rose 43% year over year to $30.8 million; net income increased more than 200% to $6.7 million, or $0.11 per diluted share.
  • Patient-affordability revenue more than doubled to $16.6 million, with claim volume up approximately 55%; revenue per program rose about 32% to $99,500.
  • Gross margin expanded 840 basis points to 64.7%, as patient affordability became a larger share of revenue.
  • PaySign launched 19 programs in Q3 and had 167 active programs; it expects to end 2026 with 190–195.
  • Plasma revenue increased 7.5% to $13.8 million, but the company expects to end the year with 445–450 centers, down from 562 at quarter-end, following the customer transition.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit PAYS on AllInvestView.

Get the Full Picture on PAYS

Track PaySign, Inc. in your portfolio with real-time analytics, dividend tracking, and more.

View PAYS Analysis